| Human |
hsa_circ_SEPT9 |
hsa_circ_0005320 |
- |
triple-negative breast carcinoma |
SEPT9 |
miR-637 |
Q
H
S
| UP |
More |
| Human |
hsa_circ_SEPT9 |
hsa_circ_0005320 |
circ_SEPT9 |
oral cavity squamous cell carcinoma |
SEPT9 |
miR-1225 |
Q
| UP |
More |
| Human |
hsa_circ_SEPT9 |
hsa_circ_0005320 |
- |
breast cancer |
SEPT9 |
miR-149-5p |
Q
| UP |
More |
| Human |
hsa_circ_SEPT9 |
hsa_circ_0005320 |
- |
oral cavity squamous cell carcinoma |
SEPT9 |
miR-486-3p, miR-637 |
Q
| UP |
More |
| Human |
hsa_circ_SEPT9 |
hsa_circ_0005320 |
Circular RNA (circRNA) septin 9 |
glioma |
SEPT9 |
miR-432-5p |
Q
| UP |
More |
| Human |
hsa_circ_SEPT9 |
- |
circular RNA septin 9 |
triple-negative breast carcinoma |
SEPT9 |
- |
Q
| UP |
More |
| Human |
hsa_circ_SEPT9 |
hsa_circ_0005320 |
hsa_-circ_0005320 |
urinary bladder carcinoma |
SEPT9 |
- |
Q
S
| UP |
More |
| Human |
hsa_circ_SEPT9 |
- |
circSEPT9 |
triple-negative breast carcinoma |
SEPT9 |
miR-515-5p |
Q
| UP |
More |
| Human |
hsa_circ_SEPT9 |
hsa_circ_0000808 |
Circ_0000808 |
non-small cell lung carcinoma |
SEPT9 |
miR-1827 |
Q
| UP |
More |
| Human |
hsa_circ_SEPT9 |
hsa_circ_0005320 |
CircSEPT9 / circRNA Septin 9 |
breast cancer |
SEPT9 |
miR-625-5p |
Q
| UP |
More |
| Human |
hsa_circ_SEPT9 |
hsa_circ_0005320 |
hsacirc_0005320 |
mucosal melanoma |
SEPT9 |
- |
Q
M
| UP |
More |
| Human |
hsa_circ_SEPT9 |
- |
circSEPT9 |
laryngeal squamous cell carcinoma |
SEPT9 |
miR-10a |
Q
| UP |
More |
| Human |
hsa_circ_SEPT9 |
- |
circSEPT9 |
endometrial cancer |
SEPT9 |
miR-186 |
Q
S
| UP |
More |